Loading...
Highly Variable Drugs: Observations from Bioequivalence Data Submitted to the FDA for New Generic Drug Applications
INTRODUCTION: It is widely believed that acceptable bioequivalence studies of drugs with high within-subject pharmacokinetic variability must enroll higher numbers of subjects than studies of drugs with lower variability. We studied the scope of this issue within US generic drug regulatory submissio...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer US
2008
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2751460/ https://ncbi.nlm.nih.gov/pubmed/18446515 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12248-008-9015-x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|